Pancreatic cancer risk: associations with 1) Meat-derived carcinogen intake (HCAs and BaP) & 2) Nucleotide excision repair (NER) (DNA repair)
Hypotheses: Pancreatic cancer risk increases with: 1) Levels of meat-borne carcinogens (measured by questionnaire) 2) Levels of PhIP-albumin adducts (a biomarker of internal dose) and 3) Low (vs. high) nucleotide excision repair (NER). Specific Aims: 1) Identify pancreatic cancer cases and controls within the PLCO study (see B.8). A case-cohort design will be used to study pancreatic cancer cases and controls. Incident cases of exocrine pancreas cancer will be eligible for these analyses (as defined in B.8.). We will identify 100 cases of incident adenocarcinoma of the pancreas, each of whom has a plasma sample and a cryopreserved whole blood sample (or lymphoblastoid cell line). Those with biological samples will be used for PhIP-Alb and NER assays. Controls will be subjects that are cancer free at baseline and at blood collection. All pancreas cancer cases, and cancer free controls (1:3 ratio) that completed the diet questionnaire, will be included for the meat analysis. 2) Derive intake levels of well-done barbecued pan-fried meat, HCAs and BaP and a mutagenic activity index from PLCO dietary questionnaires that ascertain total meat intake, cooking methods and doneness preferences. Assessment of the meat intake and doneness preferences, carcinogen variables and mutagenic index will be carried out as described by Sinha and Rothman, 1999 and as analyzed previously by our group in collaboration with Dr. Sinha (Anderson, 2002; 2005, Attached as PDFs). 3) Measure PhIP-albumin adduct (PhIP-Alb) levels in plasma samples from 200 subjects (100 cases and 100 controls). We will extract PhIP-Alb adducts from 0.5 mls of frozen stored plasma. The adducted proteins will be hydrolyzed and levels of PhIP determined with a liquid chromatography-tandem mass spectrometry method. 4) Evaluate the association of pancreatic cancer with dietary questionnaire assessments and with PhIP-albumin adduct levels. Relative risks (RRs) and their 95% confidence intervals (CI) can be estimated using kernel-smoothed life-table models with cross-validated smoothing parameters and bootstrapped confidence intervals. Relative risks for the various measures such as, types of meat intake (in daily grams), derived carcinogen variables, and PhIP-Alb levels will be modeled as smooth continuous variables and, if warranted by this analysis, ordinal categories of RR will be described. These models will be adjusted for potential confounding using propensity scores estimated from complete dietary and demographic information. 5) Culture lymphocytes from cryopreserved lymphocytes or lymphoblastoid cell lines and perform measurements of nucleotide excision repair activity on cell cultures from 200 subjects (100 cases and 100 controls) plus quality control samples (10%). The NER assay utilizes cultured lymphocytes, which can be recovered from cryopreserved or immortalized lymphocytes. Dr. Gross' laboratory has developed a protocol and has successfully cultured lymphocytes from pilot study PLCO samples. A flow cytometry-based alkaline unwinding assay has been developed, which specifically measures activity in the nucleotide excision repair pathway and provides quantitative measurements of lymphocyte NER activity. 6) Evaluate the relationship between nucleotide excision repair activity and the risk of pancreatic cancer. It is hypothesized that pre-diagnostic NER activity is lower among individuals that later develop pancreatic cancer compared to cancer-free controls. The degree of association between NER activity and pancreatic cancer will be estimated using both classical methods and logistic regression techniques.
Kristin Anderson (Division of Epidemiology & CH, U of MN)
Myron Gross (Laboratory Medicine & Pathology, U of MN)
Rashmi Sinha (NCI)
Bharat Thyagarajan (Laboratory Medicine & Pathology, U of MN)
Timothy Sielaff (Virginia Piper Cancer Institute)
Timothy Church (Division of Environmental Health, U of MN)
-
Pancreatic cancer risk: associations with meat-derived carcinogen intake in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort.
Anderson KE, Mongin SJ, Sinha R, Stolzenberg-Solomon R, Gross MD, Ziegler RG, Mabie JE, Risch A, Kazin SS, Church TR
Mol. Carcinog. 2012 Jan; Volume 51 (Issue 1): Pages 128-37 PUBMED